Effect of prostacyclin (PGI2) on platelets and fibrinolytic activity in patients with arteriosclerosis obliterans

This publication has 13 references indexed in Scilit:

• The Effect of Clinical Prostacyclin Infusions in Advanced Arterial Disease on Platelet Function and Plasma 6-keto PGF1αLevels
  British Journal of Haematology, 1981
• A double blind placebo controlled crossover study of prostacyclin in man
  Life Sciences, 1979
• Effects of PGI2 on the inactivation of thrombin, factor Xa, and plasmin by antithrombin-III and hepartin
  Prostaglandins, 1979
• Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation
  Prostaglandins, 1979
• Anti-platelet action of intravenous infusion of prostacyclin in man
  Thrombosis Research, 1978
• A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
  Prostaglandins, 1976
• Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
  Prostaglandins, 1976
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
  Nature, 1976
• Some biological effects of prostaglandin endoperoxide analogs
  Life Sciences, 1976
• Effect of intravenous prostaglandin E₂on platelet function, coagulation, and fibrinolysis
  Journal of Clinical Pathology, 1973